News

THINK Surgical Welcomes Josh DeRienzis as New Legal Leader

THINK Surgical Welcomes Josh DeRienzis as New Legal Leader

THINK Surgical's New Chief Legal Officer: Josh DeRienzis

THINK Surgical, a pioneer in orthopedic robotics, has announced the appointment of Josh DeRienzis as its Chief Legal Officer and Board Secretary. With a rich background in law and extensive experience advising senior executives and boards of directors, Josh is set to play a crucial role in the company's strategy and operations.

In his new role, Josh will work closely with Stuart Simpson, the company's President and CEO. His responsibilities will include strategic planning, compliance, business development, and overseeing the legal, human resources, and intellectual property teams. His arrival comes after the retirement of Patty Davis, the former Chief Legal Officer, who dedicated years to advancing THINK Surgical’s mission.

A Wealth of Experience in Healthcare Law

Josh brings an impressive resume to THINK Surgical, with over 25 years in the legal field. He specializes in a diverse array of areas, including mergers and acquisitions, commercial transactions, and governance. His expertise in the healthcare and medical device sectors is notable, having worked with well-known companies like Argon Medical Devices, Surgalign Holdings, and RTI Surgical.

"I am honored and privileged to join the experienced team at THINK Surgical," Josh expressed. He recognizes the rapid growth of orthopedic robotics and is eager to contribute to the company’s leadership in this field. His insights and skills are expected to drive the company’s innovative initiatives forward.

Commitment to Innovation in Orthopedic Robotics

THINK Surgical has been at the forefront of developing cutting-edge orthopedic robots that facilitate surgeries with precision and efficacy. Their open-platform robotic systems allow surgeons to choose from various implant brands, ensuring personalized patient care. This commitment to providing advanced surgical technology aligns with the increasing demand for effective treatment options for advanced joint diseases.

The company's collaboration with global healthcare professionals enhances its product refinements, ensuring they meet the specific needs of both practitioners and patients. As orthopedic robotics continues to evolve, THINK Surgical remains dedicated to improving outcomes for individuals suffering from joint ailments.

Leadership Transition and Future Directions

Stuart Simpson, the President and CEO of THINK Surgical, commented on Josh’s appointment, highlighting the importance of previous leadership transitions in shaping the company’s future. He acknowledged Patty Davis for her dedication and expressed enthusiasm for the fresh perspective that Josh will bring to the executive team.

With Josh now on board, THINK Surgical is poised to further its leadership goals in orthopedic innovation. The company aims to pave the way for new technological advancements that enhance surgical practices and improve patient care, driven by Josh’s legal expertise and strategic vision.

About THINK Surgical

THINK Surgical, Inc. is a U.S.-based technology leader focusing on orthopedic robotic systems. Their products are designed to support a variety of implant brands, emphasizing the surgeon’s choice in procedures. By integrating intelligent technology, THINK Surgical aims to offer precision in surgeries that lead to better patient outcomes.

As they navigate through the orthopedic landscape, THINK Surgical continues to prioritize collaboration with healthcare experts to innovate and refine their robotic solutions. The company believes in the potential of robotic surgery to significantly improve the lives of individuals facing joint challenges.

Frequently Asked Questions

What is the role of Josh DeRienzis at THINK Surgical?

Josh DeRienzis has been appointed as the Chief Legal Officer and Board Secretary, where he will guide legal and strategic decisions for the company.

What experience does Josh bring to THINK Surgical?

Josh brings over 25 years of experience in the legal field, with a focus on healthcare, mergers, and commercial transactions.

Why did Patty Davis retire?

Patty Davis retired after years of service, and her departure has paved the way for new leadership at THINK Surgical.

How does THINK Surgical innovate in orthopedic robotics?

THINK Surgical innovates by developing open-platform robotics that enhance surgical precision and improve patient outcomes through technological advancements.

What is the mission of THINK Surgical?

THINK Surgical’s mission is to lead in orthopedic robotics, improving surgical practices and patient care through advanced robotic technology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 5

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

XPENG Delivers 39,107 Vehicles in August 2026

Updated Category News Views 11

Grit and Green in XPENG's Latest Numbers You'd think someone at XPENG's HQ popped the champagne today, given what they're reporting, but don't let the buzz fool you. August 2026 saw them deliver 39,107 vehicles. That's a nice 4% tick up year over year. But remember, we're talking a sector where anything short of double digits can feel like a whisper instead of a roar....

Continue Reading
Artivion Set to Announce Financial Results in February 2026

Updated Category News Views 90

Artivion to Announce Fourth Quarter Financial Results Artivion, Inc. (NYSE: AORT), a renowned company in the cardiac and vascular sector, has set a date for the release of its fourth quarter financial results for the year 2025. The main announcement will occur on the afternoon of the market closing on February 12, 2026. This release is highly anticipated within investor...

Continue Reading
FibroBiologics and Charles River Unite for Cell Therapy Advancements

Updated Category News Views 181

FibroBiologics Partners with Charles River for Innovative Therapies FibroBiologics, Inc. (Nasdaq: FBLG), a pioneering biotechnology company, has announced a groundbreaking collaboration with Charles River Laboratories, a renowned name in drug discovery and manufacturing. This partnership aims to develop and manufacture advanced fibroblast cell-based therapies intended to...

Continue Reading
Axsome Therapeutics Looks Ahead with Participations in Events

Updated Category News Views 128

Axsome Therapeutics: Engaging the Investment Community Axsome Therapeutics, Inc. (NASDAQ: AXSM), a pioneering biopharmaceutical enterprise focused on revolutionary treatments for central nervous system (CNS) disorders, has exciting plans ahead as it prepares to engage with investors at significant upcoming conferences. This engagement highlights the company's commitment...

Continue Reading
Palmstreet's Bold Moves in the $68B Live Shopping Boom

Updated Category News Views 9

Palmstreet Sets the Stage for Seller Success As the live shopping phenomenon in the U.S. rivals the busiest stock market scramble, Palmstreet is laying down some serious game-changing strategies. We're staring at a market expected to hit a staggering $68 billion in 2026, more than doubling its size from three years ago. Instead of riding the coattails of this lucrative...

Continue Reading